A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes. (scientific article published on 17 May 2013)

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Q27860882

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Q27861088

Depressive symptoms and unmet psychological needs of Dutch youth with type 1 diabetes: results of a web-survey

Q30484561

Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes.

Q34153420

Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes

Q35094030

Long-term efficacy of insulin pump therapy in children with type 1 diabetes mellitus

Q36282295

Factors associated with increased risk of insulin pump discontinuation in pediatric patients with type 1 diabetes

Q37781112

Guidelines for optimal bolus calculator settings in adults

Q37838032

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

Q38025029

Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy

Q43034875

Timing of bolus in children with type 1 diabetes using continuous subcutaneous insulin infusion (TiBoDi Study).

Q43182912

Lowering postprandial glycemia in children with type 1 diabetes after Italian pizza "margherita" (TyBoDi2 Study).

Q43925567

Sustained benefits of continuous subcutaneous insulin infusion

Q44373134

Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes

Q44681500

Life with continuous subcutaneous insulin infusion (CSII) therapy: child and parental perspectives and predictors of metabolic control

Q44796639

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis

Q45247705

A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes

Q46909991

Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes

Q46955170

Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.

Q50787258

Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report.

Q51573410

P433

issue

P921

main subject

type-1 diabetes

teenager

preproinsulin

page(s)

205-210

P577

publication date

2013-05-17

P1433

published in

Acta Diabetologica

Q15749690

P1476

title

A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes.

P478

volume

Reverse relations

cites work (P2860)

Q42949384	7(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG), May 8-10, 2014, Helsinki, Finland
Q36076863	A Comparison of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Insulin Injection in Children with Type I Diabetes in Kuwait: Glycemic Control, Insulin Requirement, and BMI.
Q89159575	A Retrospective Review of the Clinical Characteristics and Blood Glucose Data from Cellnovo System Users using Data Collected from the Cellnovo Online Platform
Q90664004	A systematic review of non-genetic predictors and genetic factors of glycated haemoglobin in type 1 diabetes one year after diagnosis
Q37732214	Changes in HbA1c and Weight Following Transition to Continuous Subcutaneous Insulin Infusion Therapy in Adults With Type 1 Diabetes
Q58736708	Continuous Subcutaneous Insulin Infusion Characteristics in Type 1 Diabetes Children and Adolescents in Qatar
Q35682636	Cross-sectional survey and retrospective analysis of a large cohort of adults with type 1 diabetes with long-term continuous subcutaneous insulin infusion treatment
Q38371179	Current perspectives on physical activity and exercise for youth with diabetes
Q41544165	Ethnic differences in early glycemic control in childhood-onset type 1 diabetes
Q35843607	Explaining the increased mortality in type 1 diabetes
Q64066044	Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control
Q40101385	Optimum bolus wizard settings in insulin pumps in children with Type 1 diabetes
Q51654262	Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas.
Q38778988	Pursuit of a perfect insulin.
Q57450977	Sensor-augmented pump and Down syndrome: a new tool in tricky patients
Q40474936	Survey on the use of insulin pumps in Italy: comparison between pediatric and adult age groups (IMITA study).
Q40693872	Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes
Q34360873	The effectiveness and durability of an early insulin pump therapy in children and adolescents with type 1 diabetes mellitus
Q34282336	Trajectories of HbA1c levels in children and youth with type 1 diabetes
Q40581365	Treatment intensification without improved HbA1c levels in children and adolescents with Type 1 diabetes mellitus.
Q53427648	Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness.
Q92645523	Using insulin pump with a remote-control system in young patients with diabetes improves glycemic control and enhances patient satisfaction

P356	DOI	10.1007/S00592-013-0481-Y
P698	PubMed publication ID	23681558
P5875	ResearchGate publication ID	236863245